Short Acting Beta Agonists Sabas

Drug Overview

Time taken to compute- 0.015 sec

drug details
nameShort-Acting Beta-2 Agonists (SABAs)
classificationBronchodilators, Respiratory Agents
pharmacokinetics
absorptionRapidly absorbed following inhalation. Peak effect within minutes to 30 minutes.
distributionPrimarily distributed to the lungs.
metabolismMetabolized rapidly in the lungs and systemically.
excretionExcreted primarily via metabolism and exhalation. Elimination half-life varies by specific agent.
important notesPharmacokinetic parameters can vary slightly between different SABAs.
suggested dosage
notesDosage varies significantly depending on the specific SABA, patient's condition, and response. Always follow the instructions provided by your doctor or pharmacist, and do not exceed recommended dosages.
exampleAlbuterol inhalation, 2 puffs, every 4-6 hours as needed.
important notesNebulized forms provide more rapid delivery for acute exacerbations.
indications
1Treatment of bronchospasm and reversible airflow obstruction associated with asthma and COPD.
2Acute relief of symptoms such as wheezing, shortness of breath, and coughing.
safety pregnancy
detailsSABAs are generally considered safe for use during pregnancy if used as directed. However, potential risks should be discussed with your healthcare provider. Some studies suggest an increased risk of premature labor in higher doses.
important notesLimited data is available on long-term use.
safety breastfeeding
detailsSABAs are generally considered safe for use by breastfeeding mothers if used as directed. However, small amounts may be transferred into breast milk, and potential effects on the infant should be discussed with your healthcare provider.
important notesLimited data on long-term use and direct effects on breastfed infants.
side effects
1Tremor
2Anxiety
3Headache
4Palpitations
5Nervousness
6Nausea
7Increased heart rate
8Restlessness
9Muscle cramps
alternatives
1Long-Acting Beta-2 Agonists (LABAs)
2Theophylline
3Leukotriene Modifiers
4Anticholinergics
contraindications
1Known hypersensitivity to SABAs
2Uncontrolled heart conditions (e.g., severe arrhythmias)
3Severe uncontrolled hypertension
interactions
1Certain medications for heart conditions (beta-blockers)
2Monoamine oxidase inhibitors (MAOIs)
warnings precautions
1Use cautiously in patients with cardiovascular conditions.
2Monitor for side effects, especially in the elderly and those with pre-existing conditions.
3Do not abruptly stop use. Taper off under medical supervision.
4Avoid use in individuals known to be sensitive to sympathomimetic amines
5May potentiate other sympathomimetic drugs (other bronchodilators).
additional informations
specific notesSABAs are intended for acute use; long-term control of asthma or COPD requires additional medication(s) as prescribed by your healthcare provider.
patient specificIndividual responses to SABAs can vary significantly. Close monitoring of the patient's response to treatment is essential.
important noteThis information is for general knowledge and educational purposes only, and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.
patient specific considerations
age weightFor a 25-year-old male weighing 70 kg, dosage will be determined by the severity of their condition and the specific SABA used. Your doctor will tailor the treatment based on your needs.
important notes side effectsThese side effects are usually mild to moderate. More severe side effects are rare but possible. Report any unusual or concerning side effects to your healthcare provider immediately.

Check another drug or interactions

Most Frequent Searches

Reference Patient:(25 years,Male, 70KGs) *Not a medical advice

Get in Touch Now!

Contact Us